Answer
Whether setmelanotide passes into human milk is unknown; infant risk cannot be excluded, so breastfeeding or Imcivree treatment must be discontinued after weighing benefits for child and mother, and breastfeeding patients should be advised of potential benzyl alcohol risks.
Sources for this answer
- IMCIVREE 10 mg/ml solution for injectionRhythm Pharmaceutical UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked